Lingyan Zhu

1.2k total citations
30 papers, 945 citations indexed

About

Lingyan Zhu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Lingyan Zhu has authored 30 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Lingyan Zhu's work include Mesenchymal stem cell research (4 papers), Advanced Glycation End Products research (4 papers) and Wound Healing and Treatments (3 papers). Lingyan Zhu is often cited by papers focused on Mesenchymal stem cell research (4 papers), Advanced Glycation End Products research (4 papers) and Wound Healing and Treatments (3 papers). Lingyan Zhu collaborates with scholars based in China, United States and Switzerland. Lingyan Zhu's co-authors include Dong‐Ming Kuang, Yan Wu, Jixiong Xu, Limin Zheng, Jianying Liu, Tianlun Yang, Qiyi Zhao, Yunliang Tang, Xiangwei Xiao and Peng Chen and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Biochemical and Biophysical Research Communications.

In The Last Decade

Lingyan Zhu

30 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingyan Zhu China 18 284 282 195 169 111 30 945
Daryl M. Okamura United States 19 521 1.8× 261 0.9× 122 0.6× 132 0.8× 75 0.7× 34 1.4k
Enrique Fuentes‐Mattei United States 18 618 2.2× 131 0.5× 293 1.5× 306 1.8× 26 0.2× 23 1.1k
Domenico Liguoro Italy 19 630 2.2× 256 0.9× 307 1.6× 414 2.4× 153 1.4× 42 1.4k
Falah Almohanna Saudi Arabia 18 470 1.7× 201 0.7× 457 2.3× 199 1.2× 16 0.1× 49 1.1k
Ewa Brzeziańska‐Lasota Poland 22 664 2.3× 250 0.9× 273 1.4× 307 1.8× 195 1.8× 113 1.5k
Anne Fischer‐Nielsen Denmark 20 381 1.3× 136 0.5× 140 0.7× 146 0.9× 21 0.2× 42 1.3k
Peter Nawroth Germany 15 457 1.6× 115 0.4× 217 1.1× 176 1.0× 92 0.8× 32 1.3k
Charalambos Michaeloudes United Kingdom 16 436 1.5× 256 0.9× 69 0.4× 97 0.6× 18 0.2× 31 1.2k
Jeffrey D. Ritzenthaler United States 16 467 1.6× 145 0.5× 120 0.6× 120 0.7× 21 0.2× 35 1.2k

Countries citing papers authored by Lingyan Zhu

Since Specialization
Citations

This map shows the geographic impact of Lingyan Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Zhu more than expected).

Fields of papers citing papers by Lingyan Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingyan Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Zhu. The network helps show where Lingyan Zhu may publish in the future.

Co-authorship network of co-authors of Lingyan Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingyan Zhu. A scholar is included among the top collaborators of Lingyan Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyan Zhu. Lingyan Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gui, Qian, Yihua Zhang, Yinan Liu, et al.. (2023). Glutamylation of an HIV-1 protein inhibits the immune response by hijacking STING. Cell Reports. 42(5). 112442–112442. 10 indexed citations
2.
3.
Liu, Qun, Yinan Jiang, Lingyan Zhu, et al.. (2021). Insulin-positive ductal cells do not migrate into preexisting islets during pregnancy. Experimental & Molecular Medicine. 53(4). 605–614. 5 indexed citations
4.
Zhu, Lingyan, et al.. (2021). PlGF Reduction Compromises Angiogenesis in Diabetic Foot Disease Through Macrophages. Frontiers in Immunology. 12. 736153–736153. 9 indexed citations
5.
Zhu, Lingyan, et al.. (2020). Fendrr involves in the pathogenesis of cardiac fibrosis via regulating miR-106b/SMAD3 axis. Biochemical and Biophysical Research Communications. 524(1). 169–177. 27 indexed citations
6.
Chen, Dong‐Ping, Wan-Ru Ning, Zhi-Peng Peng, et al.. (2019). Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma. Journal of Hepatology. 71(2). 333–343. 125 indexed citations
7.
Gong, Li, Yi Xiao, Fan Xia, et al.. (2019). The mevalonate coordinates energy input and cell proliferation. Cell Death and Disease. 10(4). 327–327. 30 indexed citations
8.
Hu, Juan, Congxin Huang, Yin Zhang, et al.. (2019). MicroRNA-155 inhibition attenuates endoplasmic reticulum stress-induced cardiomyocyte apoptosis following myocardial infarction via reducing macrophage inflammation. European Journal of Pharmacology. 857. 172449–172449. 41 indexed citations
9.
Zhu, Lingyan, Qiaoqing Zhong, Tianlun Yang, & Xiangwei Xiao. (2019). Improved therapeutic effects on diabetic foot by human mesenchymal stem cells expressing MALAT1 as a sponge for microRNA-205-5p. Aging. 11(24). 12236–12245. 31 indexed citations
10.
Duan, Qiong, Zhenzhen Liu, Fan Xia, et al.. (2019). BET bromodomain inhibition suppresses adipogenesis in mice. Endocrine. 67(1). 264–267. 11 indexed citations
11.
Zhu, Lingyan, Jixiong Xu, Ying Liu, et al.. (2018). Prion protein is essential for diabetic retinopathy-associated neovascularization. Angiogenesis. 21(4). 767–775. 10 indexed citations
12.
Wang, Jiao, et al.. (2017). Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome. Medicine. 96(39). e8183–e8183. 34 indexed citations
13.
Duan, Yishuang, Lei Wang, Liping Han, et al.. (2017). Exposure to phthalates in patients with diabetes and its association with oxidative stress, adiponectin, and inflammatory cytokines. Environment International. 109. 53–63. 78 indexed citations
14.
Yang, Dafeng, Ya Wang, Xu Deng, et al.. (2017). Downregulation of Profilin-1 Expression Attenuates Cardiomyocytes Hypertrophy and Apoptosis Induced by Advanced Glycation End Products in H9c2 Cells. BioMed Research International. 2017. 1–11. 21 indexed citations
15.
Tang, Yunliang, et al.. (2017). Three-week topical treatment with placenta-derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer. Medicine. 96(51). e9212–e9212. 47 indexed citations
16.
Zhang, Wei, Weifeng Zhu, Ying Liu, et al.. (2016). Polymorphism 2184A/G in the AGER gene is not associated with diabetic retinopathy in Han Chinese patients with type 2 diabetes. Journal of International Medical Research. 44(3). 520–528. 8 indexed citations
17.
Duan, Qiong, Yi Xiao, Lingyan Zhu, et al.. (2016). BET bromodomain is a novel regulator of TAZ and its activity. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1859(12). 1527–1537. 15 indexed citations
18.
Zhao, Qiyi, Christos Xiao, Yan Wu, et al.. (2011). Interleukin‐17‐educated monocytes suppress cytotoxic T‐cell function through B7‐H1 in hepatocellular carcinoma patients. European Journal of Immunology. 41(8). 2314–2322. 77 indexed citations
19.
Kuang, Dong‐Ming, Peng Chen, Qiyi Zhao, et al.. (2010). Tumor-Activated Monocytes Promote Expansion of IL-17–Producing CD8+ T Cells in Hepatocellular Carcinoma Patients. The Journal of Immunology. 185(3). 1544–1549. 129 indexed citations
20.
Bao, Lingzhi, An Xu, Liping Tong, et al.. (2008). Activated Toxicity of Diesel Particulate Extract by Ultraviolet A Radiation in Mammalian Cells: Role of Singlet Oxygen. Environmental Health Perspectives. 117(3). 436–441. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026